Percutaneous radiofrequency ablation for osteoid osteoma: How we do it

Jankharia, Bhavin; Burute, Nishigandha

doi:10.4103/0971-3026.44523

Cited by 32 publications

(20 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…involving 40 patients, primary and secondary clinical success rates of 95% and 100%, respectively, was achieved. [ 25 ] Rehnitz et al . [ 26 ] in their retrospective analysis of 72 cases reported primary and secondary clinical success rates of 99% and 100%, respectively.…”

Section: Discussionmentioning

confidence: 99%

CT-guided radiofrequency ablation in osteoid osteoma: Result from a tertiary cancer centre in India

Kulkarni

Shetty

Polnaya

et al. 2017

Indian Journal of Radiology and Imaging

View full text Add to dashboard Cite

Aims:The aim of this study is to evaluate the clinical efficacy of computed tomography (CT)-guided radiofrequency (RF) ablation as a minimally invasive therapy for osteoid osteoma.Materials and Methods:This is a retrospective analysis of prospectively maintained data of 43 symptomatic osteoid osteoma patients who were treated by radiofrequency ablation (RFA). Forty out of 43 patients were naive cases and underwent primary treatment for osteoid osteoma with RFA, whereas 3 patients included in the study underwent RFA for local recurrence after having undergone surgical treatment. Diagnosis was based on clinical and characteristic imaging findings, and biopsy was done for cases with atypical presentation. Pre and post procedure Visual Analog Score (VAS) was documented in all cases. Monopolar RFA system was used in all patients, and the electrode was placed within the lesion nidus under CT guidance coaxially through 11G introducer needle. Ablation was performed at 90° C for 5 min.Results:Technical success rate of intranidal placement of electrode was 100%. The primary clinical success in our study was 97.7% (42 of 43), and the secondary clinical success was 100%. Pre and postprocedure VAS score in our study group was 7.8 and 0.4, respectively. Mean follow-up period in our study was 48 months (Range: 4–129 months). One patient had recurrence of pain 4 years after treatment and was treated successfully by a second session. Minor complications were seen in 3 patients with two cases of RF pad burns and one case of skin burn at the treatment site, and these were managed conservatively. No patients developed temporary/permanent neurological deficits, and no procedure-related mortality was seen in our study.Conclusion:CT-guided percutaneous RFA is a simple, safe, minimally invasive, and highly effective treatment option for osteoid osteoma with good long-term pain control and potentially low disease recurrence.

show abstract

Section: Discussionmentioning

confidence: 99%

CT-guided radiofrequency ablation in osteoid osteoma: Result from a tertiary cancer centre in India

Kulkarni

Shetty

Polnaya

et al. 2017

Indian Journal of Radiology and Imaging

View full text Add to dashboard Cite

show abstract

“…But this method may result in the wide resection of normal bone to ensure completely excise of the tumor [ 14 ]. This causes structural weakening and requires a long period of limited weight bearing and activity restriction [ 15 , 16 ]. Surgery in anatomically difficult sites such as acetabulum, glenoid, and femoral head or neck also carries high risk of complications [ 10 , 17 ].…”

Section: Discussionmentioning

confidence: 99%

Osteoid Osteoma Treated with Radiofrequency Ablation

Çakar

Esenyel

Seyran

et al. 2015

Advances in Orthopedics

View full text Add to dashboard Cite

Purpose. Our aim is to evaluate the results of treatment with computed tomography (CT) guided percutaneous radiofrequency ablation for osteoid osteomas which were localized in a difficult area for operation. Materials and Methods. Glenoid, distal tibia, humerus shaft, proximal humerus, and in third finger of the hand proximal phalanx were involved in one patient. Proximal femur was involved in three patients, distal femur was involved in three patients, and proximal tibia was involved in two patients. 9 males and 4 females were aged 4 to 34 years (mean age: 18.5 years). All patients had pain and were evaluated with X-rays, CT, bone scintigraphy, and MRI. In all patients, RF ablation was performed with local anesthesia. The lesion heated to 90°C for 6 minutes. Results. All of the patients achieved complete pain relief after ablation and were fully weight bearing without any support. In all patients, there was soft tissue edema after the procedure. During follow-up, all patients were free from the pain and there was no sign about the tumor. There was no other complication after the process. Conclusion. CT guided RFA is a minimally invasive, safe, and cost-effective treatment for osteoid osteoma placed in difficult area for surgery.

show abstract

“…2 Localized pain felt by patients was greatly reduced in all cases post-operatively, and only two patients reported mild pain at 3-month follow-up. Since osteoid osteomas are characteristic for their painful progression, the reduction of pain is significant.…”

Section: Discussionmentioning

confidence: 98%

“…1 Osteoid osteomas account for roughly 10% of all benign bone tumours and characteristically present with dull aching pain that may be relieved with non-steroidal anti-inflammatory drugs (NSAIDs). 2 They typically present in young individuals, most commonly between 7 and 25 years of age, with a male-to-female ratio of 3 : 1.…”

Section: Introductionmentioning

confidence: 99%

Radiofrequency ablation under 3D intraoperative Iso-C C-arm navigation for the treatment of osteoid osteomas

Yang¹,

Niu²,

Zhang³

et al. 2015

BJR

View full text Add to dashboard Cite

Objective: To evaluate the efficacy of intraoperative three-dimensional (3D) Iso-C C-arm-navigated percutaneous radiofrequency ablation (RFA) of osteoid osteomas. Methods: 35 patients (20 males and 15 females) with osteoid osteomas underwent treatment with intraoperative 3D Iso-C C-arm navigation-guided RFA. The tumour was first biopsied for pathological examination, the core needle was removed and the RFA needle was inserted into the nidus. Post-operative X-rays and CT scans were performed to evaluate the degree of ablation and to assess for recurrence at 3-month follow-up. Patients also completed a visual analogue scale (VAS) both preoperatively and 3 days post-operatively to subjectively assess pain. Results: Pathological diagnosis confirmed osteoid osteoma in 19 cases. The other 16 cases were not pathologically diagnosed owing to inadequate biopsy specimens. In all cases, localized pain was immediately relieved following RFA. Patients reported significantly decreased pain, with mean pre-operative VAS scores of 3.4 reducing to 0.80 at 3 days post-operatively and further to 0.06 at 3-month follow-up (p , 0.05). The mean follow-up time was 15.5 months (range: 3-38 months). Conclusion: 3D Iso-C C-arm navigation-guided RFA is a safe and effective option for the treatment of osteoid osteomas and may be considered in place of intraoperative CT-guided and open resection. Advances in knowledge: C-arm image-guided percutaneous RFA mitigates the need for pre-operative CT as well as intraoperative scintigraphy, provides real-time imaging of the anatomy, facilitates accurate resection of the tumour and enables immediate confirmation of excision.

show abstract

Percutaneous radiofrequency ablation for osteoid osteoma: How we do it

Cited by 32 publications

References 13 publications

CT-guided radiofrequency ablation in osteoid osteoma: Result from a tertiary cancer centre in India

CT-guided radiofrequency ablation in osteoid osteoma: Result from a tertiary cancer centre in India

Osteoid Osteoma Treated with Radiofrequency Ablation

Radiofrequency ablation under 3D intraoperative Iso-C C-arm navigation for the treatment of osteoid osteomas

Contact Info

Product

Resources

About